share_log

Candel Therapeutics Receives Orphan Drug Designation From European Medicines Agency For CAN-2409 In Glioma

Candel Therapeutics Receives Orphan Drug Designation From European Medicines Agency For CAN-2409 In Glioma

Candel Treateutics獲得歐洲藥品管理局指定的治療腦膠質瘤CAN-2409的孤兒藥物
Benzinga Real-time News ·  2022/09/15 08:07

Candel Therapeutics Receives Orphan Drug Designation From European Medicines Agency For CAN-2409 In Glioma

Candel Treateutics獲得歐洲藥品管理局指定的治療腦膠質瘤CAN-2409的孤兒藥物

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論